StockData
NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31

Can B Corp

Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)

Close on Oct 19, 2026

Market cap
$981.54K
P/E (TTM)
–
Dividend yield
–

Can B Corp revenue by segment

By business segment

By product or service

RevenueTTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23TTM Q2 23TTM Q1 23TTM Q4 22TTM Q3 22TTM Q2 22TTM Q1 22TTM Q4 21% of revenueYoY
Service [Member]$957.40K$1.17M$1.06M$819.63K––––––––92.6%–
Product Sales [Member]––––––$5.02M$5.52M$6.66M$5.78M$5.22M$4.16M––
Service Revenue [Member]––––––––$1.35M$1.25M$934.23K$447.55K––
Product [Member]–––$1.34M$1.93M$4.36M$5.02M$5.52M––––––

By region

From the segment and revenue-disaggregation notes of Can B's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.